Comparison of Commercially Available Assays for Infliximab Concentrations and Antibodies to Infliximab With Assays Developed at Janssen and Used in Clinical Studies of Remicade (R) : Iinfliximab in IBD Patients

Full text

oaioai:lirias.kuleuven.be:123456789/519942Last time updated on 5/16/2016

This paper was published in Lirias.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.